文献速递基础与转化研究医学人工智能与信息学

基于活动纳米传感器的小鼠肺癌尿液无创检测

Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling.
PubMed 文献 · Sci Transl Med · 2020-01-01

研究利用活动纳米传感器在两种免疫健全基因工程小鼠肺癌模型中检测局部病变,通过多重传感器组合、肺内递送与机器学习实现尿液读出,在Kras/Trp53突变模型中特异性100%、敏感性81%,在另一自发模型中特异性100%、敏感性95%。

要点

  • 活动纳米传感器肺内递送可经尿液无创检测小鼠局部肺癌。
  • Kras/Trp53突变模型中特异性100%、敏感性81%。
  • 另一自发模型中特异性100%、敏感性95%,不受LPS炎症干扰。

核心结论

  • 活动纳米传感器结合肺内递送与机器学习可在免疫健全小鼠中准确检测局部肺癌,支持临床开发。

研究设计与样本

  • 在两种免疫健全基因工程小鼠肺癌模型中评估活动纳米传感器多重组合的转化潜力。
  • 传感器组合设计基于人鼠肺腺癌转录组比较分析和重组候选蛋白酶体外切割实验。

主要发现

  • Kras和Trp53突变肺腺癌小鼠模型肺内给药证实金属蛋白酶作用,检测局部病变特异性100%、敏感性81%。
  • 另一自发肺腺癌模型中检测癌症特异性100%、敏感性95%,且不受脂多糖驱动的肺部炎症干扰。

关键数值与推荐

  • Kras/Trp53突变模型:特异性100%,敏感性81%。
  • 替代自发模型:特异性100%,敏感性95%,不受LPS炎症干扰。

临床怎么用

  • 为肺癌无创尿液检测提供临床转化依据,可能补充低剂量CT筛查的不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung cancer is the leading cause of cancer-related death, and patients most commonly present with incurable advanced-stage disease. U.S. national guidelines recommend screening for high-risk patients with low-dose computed tomography, but this approach has limitations including high false-positive rates. Activity-based nanosensors can detect dysregulated proteases in vivo and release a reporter to provide a urinary readout of disease activity. Here, we demonstrate the translational potential of activity-based nanosensors for lung cancer by coupling nanosensor multiplexing with intrapulmonary delivery and machine learning to detect localized disease in two immunocompetent genetically engineered mouse models. The design of our multiplexed panel of sensors was informed by comparative transcriptomic analysis of human and mouse lung adenocarcinoma datasets and in vitro cleavage assays with recombinant candidate proteases. Intrapulmonary administration of the nanosensors to a Kras- and Trp53-mutant lung adenocarcinoma mouse model confirmed the role of metalloproteases in lung cancer and enabled accurate detection of localized disease, with 100% specificity and 81% sensitivity. Furthermore, this approach generalized to an alternative autochthonous model of lung adenocarcinoma, where it detected cancer with 100% specificity and 95% sensitivity and was not confounded by lipopolysaccharide-driven lung inflammation. These results encourage the clinical development of activity-based nanosensors for the detection of lung cancer.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Kirkpatrick JD, Warren AD, Soleimany AP, et al. Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling. Sci Transl Med. 2020. PMID: 32238573. doi:10.1126/scitranslmed.aaw0262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。